6 news items
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
AAWH
ASPI
ATRA
12 Jun 24
, innovative products & services, focused strategy, execution, and the overall potential for long-term growth
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
AAWH
ASPI
ATRA
11 Jun 24
teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical's Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
ICU
7 Jun 24
to lower its inflammatory environment and focus on repair. This unique immunomodulation approach may promote long-term organ recovery and eliminate
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
ICU
14 May 24
require kidney replacement therapy (KRT) survive, with those surviving at risk of long-term, life-threatening conditions such as chronic kidney disease
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
ICU
17 Apr 24
therapy (KRT) survive, with those surviving at risk of long-term life-threatening conditions such as chronic kidney disease. Pooled analysis from two
5ujyq9vbutkl84wgxq7tuwtlyc1c1od bc8c17bb0j3ef567w7wm8
ICU
27 Mar 24
approach may promote long-term organ recovery and eliminate the need for future KRT, including dialysis. Quelimmune is the official brand name
- Prev
- 1
- Next